Asset Details
Do you wish to reserve the book?
Trends in Outcomes of Transcatheter and Surgical Aortic Valve Replacement in the United States (2012–2017)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Trends in Outcomes of Transcatheter and Surgical Aortic Valve Replacement in the United States (2012–2017)
Do you wish to request the book?
Trends in Outcomes of Transcatheter and Surgical Aortic Valve Replacement in the United States (2012–2017)
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Trends in Outcomes of Transcatheter and Surgical Aortic Valve Replacement in the United States (2012–2017)
2021
Overview
As the use of transcatheter aortic valve implantation (TAVI) expands to varying patient populations, impacting the landscape of surgical aortic valve replacement (SAVR), this study sought to assess volume and performance trends of aortic valve replacement (AVR) in the United States during 2012–2017. The Nationwide Readmissions Database was queried for patients who underwent endovascular/transapical TAVI, isolated SAVR, or complex aortic valve surgery between 2012 and 2017. Temporal trends in annual case volume, admission costs, in-hospital outcomes, and 30-day readmission were evaluated. Of 624,303 patients (median age 72 years) who received AVR, 387,011 (62%) were men. Among these patients, 170,521 (27%) underwent TAVI and 453,782 (73%) underwent SAVR with 299,398 isolated and 154,384 complex aortic valve surgery. TAVI patients were significantly older and higher risk compared with SAVR patients. From 2012 to 2017, the annual number of TAVI increased from 8,295 to 55,168 whereas SAVR volume remained remarkably stable. Patients who underwent AVR demonstrated significant improvements in mortality, stroke, duration of hospitalization, and 30-day readmission. In conclusion, this large contemporary analysis reports the considerable growth of AVR in the United States. It remains unequivocal that the treatment of aortic stenosis is improving overall with reduced mortality following AVR, highlighting the effectiveness of various process improvements such as newer valves, enhanced patient selection, and the interdisciplinary Heart Team approach.
Publisher
Elsevier Inc,Elsevier Limited
Subject
Acute Kidney Injury - epidemiology
/ Aged
/ Aorta
/ Aortic Valve Stenosis - surgery
/ Blood Transfusion - statistics & numerical data
/ Cardiac Conduction System Disease - epidemiology
/ Cardiac Conduction System Disease - therapy
/ Female
/ Heart Valve Prosthesis Implantation - trends
/ Humans
/ Kidneys
/ Male
/ Patient Readmission - trends
/ Patients
/ Postoperative Complications - epidemiology
/ Stenosis
/ Stroke
/ Surgery
/ Transcatheter Aortic Valve Replacement - trends
/ Trends
